Structures by: Raghavaiah P.
Total: 29
C20H18ClN3OS
C20H18ClN3OS
Organic & biomolecular chemistry (2010) 8, 21 4960-4970
a=7.2935(2)Å b=12.3730(3)Å c=20.6291(5)Å
α=90.00° β=90.00° γ=90.00°
C20H18ClN3OS
C20H18ClN3OS
Organic & biomolecular chemistry (2010) 8, 21 4960-4970
a=7.5879(2)Å b=10.1912(2)Å c=24.2981(4)Å
α=90.00° β=90.00° γ=90.00°
C27H23Cl2N3OS
C27H23Cl2N3OS
Organic & biomolecular chemistry (2010) 8, 21 4960-4970
a=9.7540(9)Å b=9.3273(8)Å c=13.3001(12)Å
α=90.00° β=89.90° γ=90.00°
C27H23Cl2N3OS
C27H23Cl2N3OS
Organic & biomolecular chemistry (2010) 8, 21 4960-4970
a=10.8114(11)Å b=10.9871(11)Å c=11.0108(11)Å
α=90.00° β=107.048(2)° γ=90.00°
C24H19NO
C24H19NO
Organic & biomolecular chemistry (2014) 12, 18 2869-2873
a=9.2718(19)Å b=9.5841(14)Å c=10.4920(15)Å
α=73.388(13)° β=84.716(14)° γ=79.196(15)°
Fe3(O)(CH3COO)6(C5H5NO)2(H2O).ClO4.4H2O
Fe3(O)(CH3COO)6(C5H5NO)2(H2O).ClO4.4H2O
New Journal of Chemistry (2003)
a=16.810(3)Å b=17.682(3)Å c=24.199(4)Å
α=90.000(14)° β=90.000(14)° γ=90.000(14)°
C22H27CoN2O9
C22H27CoN2O9
New J. Chem. (2015) 39, 1 200
a=15.959(5)Å b=11.194(3)Å c=13.281(4)Å
α=90.00° β=100.678(5)° γ=90.00°
C26H25NO5
C26H25NO5
RSC Adv. (2014) 4, 40 21054
a=16.104(6)Å b=6.924(3)Å c=22.877(7)Å
α=90.00° β=117.522(19)° γ=90.00°
C12H26N4O11S2
C12H26N4O11S2
Chemical Communications (2006) 26
a=26.946(2)Å b=9.5581(9)Å c=7.5203(7)Å
α=90.00° β=93.2080(10)° γ=90.00°
C4H8CoNa2O14,2(H2O)
C4H8CoNa2O14,2(H2O)
Dalton transactions (Cambridge, England : 2003) (2016) 45, 20 8500-8505
a=6.7969(6)Å b=6.9292(6)Å c=8.8126(8)Å
α=86.786(3)° β=67.652(3)° γ=89.192(3)°
C68H44Co2N4O6
C68H44Co2N4O6
Dalton transactions (Cambridge, England : 2003) (2016) 45, 4 1443-1454
a=11.840(3)Å b=12.679(3)Å c=37.680(8)Å
α=90.00° β=95.358(4)° γ=90.00°
C52H36Co2N4O6
C52H36Co2N4O6
Dalton transactions (Cambridge, England : 2003) (2016) 45, 4 1443-1454
a=26.3438(6)Å b=12.3067(3)Å c=28.9628(7)Å
α=90.00° β=90.00° γ=90.00°
C52H36Cu2N4O6,2(CH2Cl2)
C52H36Cu2N4O6,2(CH2Cl2)
Dalton transactions (Cambridge, England : 2003) (2016) 45, 4 1443-1454
a=16.5132(3)Å b=14.6766(2)Å c=19.2170(3)Å
α=90.00° β=96.1890(10)° γ=90.00°
2(C68H44Cu2N4O6),8(O),CCl3
2(C68H44Cu2N4O6),8(O),CCl3
Dalton transactions (Cambridge, England : 2003) (2016) 45, 4 1443-1454
a=19.0398(9)Å b=21.6349(7)Å c=31.0856(15)Å
α=90.00° β=100.470(5)° γ=90.00°
C24H34N6
C24H34N6
Acta Crystallographica Section B (2016) 72, 5 709-715
a=8.7977(9)Å b=10.3488(10)Å c=13.4887(10)Å
α=84.101(7)° β=87.035(7)° γ=73.903(9)°
C24H22N6
C24H22N6
Acta Crystallographica Section B (2016) 72, 5 709-715
a=8.2134(11)Å b=12.2105(11)Å c=21.052(3)Å
α=90° β=90° γ=90°
C22H30N6
C22H30N6
Acta Crystallographica Section B (2016) 72, 5 709-715
a=13.1430(12)Å b=10.3517(9)Å c=16.1607(15)Å
α=90° β=101.6510(10)° γ=90°
C6H7NO5
C6H7NO5
Acta Crystallographica Section B (2014) 70, 6 942-947
a=8.1895(7)Å b=9.8902(9)Å c=10.6709(9)Å
α=113.3760(10)° β=104.2500(10)° γ=103.4720(10)°
C5H6N2O4
C5H6N2O4
Acta Crystallographica Section B (2014) 70, 6 942-947
a=10.4325(8)Å b=6.7755(12)Å c=18.6056(14)Å
α=90.00° β=90.00° γ=90.00°
Bis[benzyl(methyl)ammonium] tetrathiomolybdate(VI)
2(C8H12N),MoS42
Acta Crystallographica Section E (2007) 63, 11 m2737-m2738
a=7.1857(12)Å b=10.7376(18)Å c=14.881(2)Å
α=110.811(2)° β=90.608(3)° γ=100.504(3)°
2,2,4-Trimethyl-2,3-dihydro-1H-1,5-benzodiazepin-5-ium 3,5-dihydroxybenzoate
C12H17N2,C7H5O4
Acta Crystallographica Section E (2007) 63, 12 o4909-o4909
a=18.718(4)Å b=9.924(2)Å c=9.696(2)Å
α=90.00° β=90.00° γ=90.00°
Strontium 4-nitrobenzoate nonahydrate
C7H18NO11Sr,C7H4NO4,2H2O
Acta Crystallographica Section E (2007) 63, 9 m2251-m2252
a=6.7364(7)Å b=11.1705(12)Å c=31.738(3)Å
α=90.00° β=95.568(2)° γ=90.00°
Diethyleneglycol bis(allylsulfonate)
C10H18O7S2
Acta Crystallographica Section E (2007) 63, 10 o4166-o4166
a=12.022(3)Å b=8.3484(18)Å c=14.894(3)Å
α=90.00° β=101.096(3)° γ=90.00°
Bis[benzyl(methyl)ammonium] tetrasulfidotungstate(VI)
2(C8H12N),S4W2
Acta Crystallographica Section E (2007) 63, 12 m3100-m3101
a=7.2178(12)Å b=10.7965(19)Å c=14.900(3)Å
α=111.057(2)° β=90.539(2)° γ=100.584(2)°
3-(7,8,13,14-Tetrahydrodibenzo[<i>a</i>,<i>i</i>]phenanthridin-5-yl)benzene- 1,2-diol
C27H21NO2
Acta Crystallographica Section E (2010) 66, 7 o1753
a=11.4002(10)Å b=10.2254(7)Å c=17.3674(16)Å
α=90.00° β=106.188(10)° γ=90.00°
(7<i>E</i>)-5-Benzyl-7-(2-chlorobenzylidene)-3-(2-chlorophenyl)-2-phenyl- 3,3a,4,5,6,7-hexahydro-2<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine
C32H27Cl2N3
Acta Crystallographica Section E (2010) 66, 7 o1734
a=13.7117(7)Å b=15.4451(6)Å c=13.6896(9)Å
α=90.00° β=113.135(7)° γ=90.00°
Bis(acac)-(4-pyrrolidino)pyridinozinc(II)
C19H26N2O4Zn
Crystal Growth & Design (2003) 3, 5 631
a=10.994(6)Å b=12.322(12)Å c=15.365(15)Å
α=90.00° β=104.93(6)° γ=90.00°
Bis(acac)-(4-pyrrolidino)pyridinozinc(II)
C19H26N2O4Zn
Crystal Growth & Design (2003) 3, 5 631
a=11.1810(8)Å b=28.583(3)Å c=12.3090(10)Å
α=90.00° β=90.00° γ=90.00°
C52H36Cu2N4O6,C2H5.5OS
C52H36Cu2N4O6,C2H5.5OS
Dalton transactions (Cambridge, England : 2003) (2016) 45, 4 1443-1454
a=26.2828(4)Å b=12.25878(17)Å c=28.8218(4)Å
α=90.00° β=90.00° γ=90.00°